Contact this company: 702-839-7200
How does the role of Daniel Montano contribute to the CardioVascular BioTherapeutics executive team? With Hoover's you get up-to-date information on CardioVascular BioTherapeutics executives, officers, and board members. Executive biographies usually include recent work history, salary, career progression, and a review of other company affiliations. Salary and bonus are provided for CardioVascular BioTherapeutics executives when available.
CALL NOW or register below to learn how you can access all of CardioVascular BioTherapeutics's executive information.
Daniel C. Montano is a Co-Founder of the Company and has been Chairman of the Board, Co-President and Chief Executive Officer since 1998. Mr. Montano is also currently the Chairman of the Board, President and Chief Executive Officer of Phage Biotechnology Corporation ("Phage"), an affiliated biotechnology company that manufactures recombinant protein drugs and is the Company's sole supplier of its drug candidates. Additionally, Mr. Montano has been a member of the Board of Directors for Cardio ...
View more information on CardioVascular BioTherapeutics.
Buy the complete Hoover's company report on CardioVascular BioTherapeutics
Obtain a roster of the CardioVascular BioTherapeutics executives, and CardioVascular BioTherapeutics executive biographies. Executive data provided by Hoover's includes expansive lists of up to 200 key employees, officers, and board members per company. Name, title, salary, bonus, age, and biography are provided for company management when available.
Learn how to get full access to executives for over 28 million businesses.
